These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 11730844)
1. Biodegradable poly (DL-lactide glycolide) microparticles as a vehicle for allergen-specific vaccines: a study performed with Ole e 1, the main allergen of olive pollen. Batanero E; Barral P; Villalba M; Rodríguez R J Immunol Methods; 2002 Jan; 259(1-2):87-94. PubMed ID: 11730844 [TBL] [Abstract][Full Text] [Related]
2. Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization. Marazuela EG; Prado N; Moro E; Fernández-García H; Villalba M; Rodríguez R; Batanero E Clin Exp Allergy; 2008 Mar; 38(3):520-8. PubMed ID: 18205856 [TBL] [Abstract][Full Text] [Related]
3. Encapsulation of Ole e 1 in biodegradable microparticles induces Th1 response in mice: a potential vaccine for allergy. Batanero E; Barral P; Villalba M; Rodríguez R J Control Release; 2003 Oct; 92(3):395-8. PubMed ID: 14568420 [TBL] [Abstract][Full Text] [Related]
4. Preliminary assessment of the immune response to Olea europaea pollen extracts encapsulated into PLGA microspheres. Igartua M; Hernández RM; Gutierro I; Gascón AR; Pedraz JL Pharm Dev Technol; 2001 Nov; 6(4):621-7. PubMed ID: 11775962 [TBL] [Abstract][Full Text] [Related]
5. Allergen-loaded biodegradable poly(D,L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model. Schöll I; Weissenböck A; Förster-Waldl E; Untersmayr E; Walter F; Willheim M; Boltz-Nitulescu G; Scheiner O; Gabor F; Jensen-Jarolim E Clin Exp Allergy; 2004 Feb; 34(2):315-21. PubMed ID: 14987314 [TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens. Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019 [TBL] [Abstract][Full Text] [Related]
7. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles. Kim SY; Doh HJ; Ahn JS; Ha YJ; Jang MH; Chung SI; Park HJ Vaccine; 1999 Feb; 17(6):607-16. PubMed ID: 10075169 [TBL] [Abstract][Full Text] [Related]
8. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems. Delgado A; Lavelle EC; Hartshorne M; Davis SS Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065 [TBL] [Abstract][Full Text] [Related]
9. Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy. Schöll I; Kopp T; Bohle B; Jensen-Jarolim E Immunol Allergy Clin North Am; 2006 May; 26(2):349-64, ix. PubMed ID: 16701149 [TBL] [Abstract][Full Text] [Related]
10. Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity. Murillo M; Gamazo C; Irache JM; Goñi MM J Drug Target; 2002 May; 10(3):211-9. PubMed ID: 12075822 [TBL] [Abstract][Full Text] [Related]
11. Vaccine properties of antigens entrapped in microparticles produced by spray-drying technique and using various polyester polymers. Baras B; Benoit M; Poulain-Godefroy O; Schacht A; Capron A; Gillard J; Riveau G Vaccine; 2000 Feb; 18(15):1495-505. PubMed ID: 10618547 [TBL] [Abstract][Full Text] [Related]
12. Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres. Rojas J; Pinto-Alphandary H; Leo E; Pecquet S; Couvreur P; Fattal E Int J Pharm; 1999 Jun; 183(1):67-71. PubMed ID: 10361157 [TBL] [Abstract][Full Text] [Related]
14. PLGA microparticles: possible vehicles for topical drug delivery. de Jalón EG; Blanco-Príeto MJ; Ygartua P; Santoyo S Int J Pharm; 2001 Sep; 226(1-2):181-4. PubMed ID: 11532580 [TBL] [Abstract][Full Text] [Related]
15. Pollen from different olive tree cultivars contains varying amounts of the major allergen Ole e 1. Castro AJ; de Dios Alché J; Cuevas J; Romero PJ; Alché V; Rodríguez-García MI Int Arch Allergy Immunol; 2003 Jul; 131(3):164-73. PubMed ID: 12876406 [TBL] [Abstract][Full Text] [Related]
16. Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles. Singh M; Shirley B; Bajwa K; Samara E; Hora M; O'Hagan D J Control Release; 2001 Jan; 70(1-2):21-8. PubMed ID: 11166404 [TBL] [Abstract][Full Text] [Related]
17. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Lavelle EC; Yeh MK; Coombes AG; Davis SS Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157 [TBL] [Abstract][Full Text] [Related]
18. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments. Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512 [TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical evaluation of gas-filled microparticles as gene delivery system. Seemann S; Hauff P; Schultze-Mosgau M; Lehmann C; Reszka R Pharm Res; 2002 Mar; 19(3):250-7. PubMed ID: 11934230 [TBL] [Abstract][Full Text] [Related]
20. A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in DL-PLG microparticles using supercritical fluids. Ghaderi R; Artursson P; Carlfors J Eur J Pharm Sci; 2000 Mar; 10(1):1-9. PubMed ID: 10699378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]